priority review - Robuta Search

https://www.gsk.com/en-gb/media/press-releases/linerixibat-accepted-for-priority-review-in-china-for-cholestatic-pruritus-in-patients-with-primary-biliary-cholangitis/ Linerixibat accepted for priority review in China for cholestatic pruritus in patients with primary... Submission based on data from positive GLISTEN phase III trial priority review in china https://www.fda.gov/patients/fast-track-breakthrough-therapy-accelerated-approval-priority-review/priority-review Priority Review | FDA priority review fda https://www.techtarget.com/pharmalifesciences/news/366607532/Bristol-Myers-Squibb-Gets-FDA-Priority-Review-for-T-Cell-Therapy Bristol Myers Squibb Gets FDA Priority Review for T-Cell Therapy | TechTarget Bristol Myers Squibb recieves FDA priority review for its T-cell therapy four months after the company received a Refusal to File letter regarding the... bristol myers squibb priority review https://www.fiercebiotech.com/biotech/advanced-accelerator-applications-gains-fda-priority-review-for-cancer-med Advanced Accelerator Applications gains FDA priority review for Novartis rival | Fierce Biotech Jun 27, 2016 - Advanced Accelerator Applications ($AAAP), which focuses on molecular nuclear medicine, will have its NDA assessed under a priority review for Lutathera--a... accelerator applications priority review https://www.tga.gov.au/products/regulations-all-products/tga-reforms/medical-devices-reforms/medical-devices-reforms-priority-review-pathway Medical devices reforms: priority review pathway | Therapeutic Goods Administration (TGA) Jan 17, 2026 - Priority review can provide faster access to medical devices. medical devices priority review reforms pathway therapeutic https://investingnews.com/tag/priority-review priority review | INN priority review inn https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/tropical-disease-priority-review-voucher-program Tropical Disease Priority Review Voucher Program | FDA FDA provides information the tropical disease priority review voucher program. priority review voucher tropical disease program fda https://www.tga.gov.au/products/biologicals/application-and-market-authorisation/supply-biological/application-process-supplying-biological/priority-review-pathway-biologicals Priority review pathway for biologicals | Therapeutic Goods Administration (TGA) Nov 5, 2025 - Information on the stages of preparation, and application for Class 2, 3 or 4 biologicals using priority pathway. priority review pathway biologicals therapeutic goods https://www.fiercebiotech.com/keyword/fda-priority-review FDA priority review | Fierce Biotech priority review fda fierce biotech https://www.biospace.com/neurotech-pharmaceuticals-inc-receives-priority-review-of-biologics-license-application-bla-for-nt-501-revakinagene-taroretcel-as-a-treatment-for-macular-telangiectasia-type-2-mactel Neurotech Pharmaceuticals, Inc. Receives Priority Review of Biologics License Application (BLA) for... Jun 20, 2024 - Neurotech Pharmaceuticals, Inc. announces that the U.S. Food and Drug Administration (FDA), has determined that the Biologic License Application (BLA) for... biologics license application priority review https://www.marketscreener.com/news/praxis-precision-medicines-gets-fda-priority-review-for-relutrigine-ce7e51d9df8ff22d Praxis Precision Medicines Gets FDA Priority Review for Relutrigine | MarketScreener Mar 30, 2026 - By Elias Schisgall Praxis Precision Medicines' New Drug Application for relutrigine will receive priority review by the Food and Drug Administration. The... priority review praxis precision medicines gets https://www.fda.gov/regulatory-information/search-fda-guidance-documents/tropical-disease-priority-review-vouchers Tropical Disease Priority Review Vouchers | FDA tropical disease priority review vouchers fda https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/fact-sheets/priority-review-drug-submissions-therapeutic-products.html Priority Review of Drug Submissions (Therapeutic Products) - Canada.ca 2002 Health Canada fact sheet priority review therapeutic products drug submissions canada https://www.merck.com/news/fda-accepts-supplemental-biologics-license-application-assigns-priority-review-and-grants-breakthrough-therapy-designation-to-mercks-keytruda-pembrolizumab-for-first-line-treatment-o/ FDA Accepts Supplemental Biologics License Application, Assigns Priority Review and Grants... May 11, 2026 - Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority... biologics license application priority review fda accepts supplemental https://www.fiercebiotech.com/biotech/ever-optimists-biogen-secures-priority-review-als-drug-failed-phase-3 Biogen secures priority review for ALS drug that failed phase 3 Jul 26, 2022 - Biogen has used 12-month data to secure priority review status for a new drug application of its amyotrophic lateral sclerosis drug tofersen. priority review biogen secures https://www.techtarget.com/pharmalifesciences/news/366606818/FDA-Grants-Priority-Review-for-Non-Small-Cell-Lung-Cancer-Drug FDA Grants Priority Review for Non-Small Cell Lung Cancer Drug | TechTarget FDA grants priority review for AstraZeneca's Enhertu to treat adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC) whose tumors... non small cell lung cancer priority review https://www.jnj.com/media-center/press-releases/us-fda-grants-priority-review-to-bedaquiline-tmc207-for-multi-drug-resistant-tuberculosis-treatment U.S. FDA Grants Priority Review to Bedaquiline (TMC207) for Multi-Drug Resistant Tuberculosis... u s fda https://www.amgen.com/newsroom/press-releases/2023/12/fda-grants-priority-review-to-amgens-tarlatamab-application-for-advanced-small-cell-lung-cancer FDA GRANTS PRIORITY REVIEW TO AMGEN'S TARLATAMAB APPLICATION FOR ADVANCED SMALL CELL LUNG CANCER|... https://www.marketscreener.com/news/merck-announces-fda-grants-priority-review-for-keytruda-and-keytruda-qlex-each-with-padcev-for-cispl-ce7f59dada8bfe25 Merck Announces FDA Grants Priority Review For Keytruda And Keytruda Qlex Each With Padcev For... Apr 20, 2026 - Merck announced that the U.S. Food and Drug Administration granted priority review for two supplemental Biologics License Applications for KEYTRUDA and...